CIRCULAR CODE BIOLOGY
Ring Code Bio is a biomedical company that develops nucleic acid drugs based on a unique circular RNA technology platform.
CIRCULAR CODE BIOLOGY
Industry:
Biopharma Biotechnology Genetics Pharmaceutical
Founded:
2021-06-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.circodebio.cn
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
20 M USD
Technology used in webpage:
SSL By Default Nginx TrustAsia DNS Pod
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Investors List
Kaitai Capital
Kaitai Capital investment in Seed Round - Circular Code Biology
Cowin Capital
Cowin Capital investment in Seed Round - Circular Code Biology
Kunlun Capital
Kunlun Capital investment in Seed Round - Circular Code Biology
Yifeng Capital
Yifeng Capital investment in Seed Round - Circular Code Biology
More informations about "Circular Code Biology"
环码生物CirCode
环码生物依托专有技术平台，在环形rna成药的两大难点环化制备与高效翻译上均具有突出优势，从而帮助环码生物探索具有更高效力的治疗模式，构建下一代mrna治疗平台。See details»
Circular Code Biology - Crunchbase Company Profile
Www.circodebio.cn ; 75,590; Highlights. obfuscated. Total Funding Amount . Unlock for free . Investors 5. Similar Companies 6. ... Contact Email …See details»
环码生物CirCode
环码生物致力于将mRNA科学的全部潜力兑现给患者See details»
CirCode - Crunchbase Company Profile & Funding
Contact Email [email protected]; CirCode Bio is an innovative biotechnology company focusing on the development of circular RNA nucleic acid drugs. …See details»
CirCode Company Profile 2024: Valuation, Funding & Investors
CirCode General Information Description. Developer of new biomedicine and drugs. The company is committed to utilizing mRNA biotechnology capabilities to design and develop new medical …See details»
CirCode - VentureRadar
"Founded in June 2021, Shanghai Circode Biopharmaceutical Co., Ltd. is an innovative biotechnology company focusing on the development of circular RNA nucleic acid drugs.See details»
环码同行 共创共赢 | 上海环码生物医药有限公司乔迁开 …
Feb 14, 2023 2022年9月21日，上午9时30分 上海环码生物医药有限公司乔迁开业庆典在上海浦东外高桥·复旦科技 园创新 中心隆重举行。 当天，来自政府、外高桥保税区、学术界、产业界近百位嘉宾及 环码员工 出席了乔迁开业庆典，共 …See details»
关于我们 - 环码生物CirCode - m.circodebio.cn
Yun Yang. Co-founder , CTO. Dr. Yun Yang graduated from Zhejiang University with a degree in Bioinformatics and earned his Ph.D. in Molecular Biology and Biochemistry from the same …See details»
关于我们 - 环码生物CirCode - m.circodebio.cn
杨赟. 联合创始人/ 首席技术官 杨赟博士毕业于浙江大学获得生物信息学学位，并在浙江大学获得分子生物学和生物化学专业博士学位，后在美国北卡罗莱纳大学教堂山分校和加州大学洛杉矶分校完成博士后研究。See details»
环码生物CirCode - 环码生物CirCode - circodebio.com
环码生物致力于将mRNA科学的全部潜力兑现给患者See details»
环码生物完成数千万美元A轮融资 - 环码生物CirCode
上海–2023年8月15日，上海环码生物医药有限公司（以下简称“环码生物”），一家基于独特环形rna技术平台开发核酸药物的创新生物医药公司，宣布完成数千万美金a轮融资。See details»
环码生物CirCode - m.circodebio.cn
For a long time, circRNAs have been considered a long non-coding RNA. The CirCode team recently found that circRNAs can produce functional proteins in a cap-independent manner …See details»
环码生物CirCode
环形RNA通常被认为是一类非编码RNA，但环码生物的科学团队发现环形RNA可以利用内部核糖体进入位点（Internal Ribosome Entry Site）或特定的RNA修饰及序列启动环形RNA的非帽依赖 …See details»
Series A - Circular Code Biology - 2023-08-15 - Crunchbase
Aug 15, 2023 Organization Name . Circular Code Biology . Announced Date Aug 15, 2023; Closed On Date Aug 15, 2023; Funding Type Series A; Funding Stage Early Stage Venture; ...See details»
环码生物CirCode - 环码生物CirCode
不同于线性rna，环形rna的翻译起始是利用特定的翻译起始元件，通过帽非依赖性的方式启动翻译。尽管这些翻译起始元件的活性弱于mrna的5’帽结构，但其具有一定的细胞和组织特异性。See details»
环码生物CirCode - 环码生物CirCode - circodebio.com
Dr. Chenxiang Tang graduated from Tsinghua University with dual degrees in Life Sciences and Economics, and earned his Ph.D. in Molecular Biophysics and Biochemistry from Yale …See details»
环码生物CirCode - 环码生物CirCode
环码生物致力于将mRNA科学的全部潜力兑现给患者See details»
环码生物CirCode - 环码生物CirCode
2024年8月14日，环形rna药物-hm2002注射液首个临床试验在上海交通大学医学院附属瑞金医院正式启动。该研究是一项研究者发起的临床试验（iit）研究，由瑞金医院心血管外科赵强教授发 …See details»
CirCode Biomed Closes Multi-Million-Dollar Series A Financing
Shanghai, China – Aug.15 th, 2023, CirCode Biomed, an innovative biotechnology company focusing on the development of Circular RNA therapeutics, announced the completion of a …See details»
环码生物宣布与辉瑞达成研发合作协议，共同探索环形RNA疗法的 …
Jul 13, 2023 中国上海—— 环码生物 宣布与辉 瑞达成研发 合作协议，双方将共同探索环形rna疗法的潜力。 本次合作将充分 发挥环码生物 独有的环形rna技术平台，结合辉瑞在制药行业的 …See details»